American Society of Hematology

SHERPA: Blue

People

  1. Park
    Park
  2. Abdel-Wahab
    Abdel-Wahab
  3. Curran
    Curran
  4. Devlin
    Devlin
  5. Sadelain
    Sadelain
  6. Wang
    Wang
  7. Berger
    Berger
  8. Bernal
    Bernal
  9. Durham
    Durham
  10. Kernan
    Kernan

Groups

  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. GSK Faculty (6)
  6. Tow Center for Developmental Oncology (TCDO) (5)
  7. Molecular Pharmacology and Chemistry Program Faculty (4)
  8. Sloan Kettering Institute Faculty (4)
  9. Executive Committee, Center for Hematologic Malignancies (3)
  10. Hematologic Malignancies Research (3)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Jae Park"
  3. "Blood"
  4. "2015"
Formats
  1. Meeting Abstract (7)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. GSK Faculty (6)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Jae Park (7)
  2. Bartlomiej Getta (3)
  3. Martin Tallman (3)
  4. Omar Abdel-Wahab (3)
  5. Craig Sauter (2)
  6. Isabelle Riviere (2)

More People

Years
  1. 2015 (7)
Publications
  1. Blood (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of targeted alpha-particle immunotherapy with actinium-225 ((225)Ac)-lintuzumab (Anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Levy, M. Y.; Estey, E. H.; Perl, A. E.; Kantarjian, H.; Earle, D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Cytogenetics in hairy cell leukemia at diagnosis and relapse: The rate of therapy-related myeloid malignancies is low
    Meeting Abstract

    Getta, B.; Abdel-Wahab, O.; Park, J. H.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse mechanisms of vemurafenib resistance in BRAF-mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Durham, B.; Chung, Y. R.; Scott, S.; Getta, B.; Kim, E.; Saven, A.; Stone, R. M.; Rai, K. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Effects of obesity on the efficacy and toxicity of induction chemotherapy in adult acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Peterson, T. J.; Lin, A.; Hilden, P.; Devlin, S.; Adel, N. G.; Park, J. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Hairy cell leukemia variant has similar survival to classical disease despite poorer responses to initial therapy: A 30-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Woo, K. M.; Devlin, S.; Park, J. H.; Abdel-Wahab, O.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save